Henshaw Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,506
Closed -$1.28M 292
2025
Q2
$1.28M Sell
18,506
-4,483
-20% -$305K 0.05% 123
2025
Q1
$1.6M Buy
22,989
+8,192
+55% +$677K 0.07% 101
2024
Q4
$1.27M Buy
14,797
+3,094
+26% +$335K 0.05% 105
2024
Q3
$1.39M Buy
11,703
+8,312
+245% +$1.11M 0.06% 105
2024
Q2
$484K Buy
3,391
+116
+4% +$15.4K 0.02% 177
2024
Q1
$421K Sell
3,275
-101
-3% -$12K 0.02% 198
2023
Q4
$349K Buy
3,376
+436
+15% +$43.1K 0.02% 220
2023
Q3
$267K Sell
2,940
-776
-21% -$68.4K 0.02% 238
2023
Q2
$301K Hold
3,716
0.02% 181
2023
Q1
$296K Sell
3,716
-496
-12% -$35.2K 0.02% 182
2022
Q4
$285K Sell
4,212
-9,272
-69% -$544K 0.02% 184
2022
Q3
$672K Buy
13,484
+370
+3% +$19.8K 0.05% 121
2022
Q2
$731K Sell
13,114
-210
-2% -$11.7K 0.05% 121
2022
Q1
$740K Hold
13,324
0.04% 131
2021
Q4
$746K Sell
13,324
-4,928
-27% -$267K 0.04% 131
2021
Q3
$876K Buy
18,252
+654
+4% +$31.6K 0.05% 114
2021
Q2
$737K Hold
17,598
0.05% 132
2021
Q1
$593K Hold
17,598
0.04% 149
2020
Q4
$615K Sell
17,598
-1,644
-9% -$56.8K 0.05% 136
2020
Q3
$668K Buy
19,242
+5,236
+37% +$175K 0.05% 126
2020
Q2
$459K Buy
14,006
+1,146
+9% +$36.6K 0.04% 153
2020
Q1
$387K Buy
12,860
+5,506
+75% +$164K 0.04% 166
2019
Q4
$213K Buy
+7,354
New +$204K 0.02% 257
2016
Q4
Sell
-12,542
Closed -$261K 283
2016
Q3
$261K Sell
12,542
-6,056
-33% -$150K 0.03% 228
2016
Q2
$500K Hold
18,598
0.07% 115
2016
Q1
$504K Buy
+18,598
New +$498K 0.07% 118

Other funds holding NVO